Search Results - "Karikó, Katalin"
-
1
Developing mRNA for Therapy
Published in Keio journal of medicine (2022)“…Messenger RNA was discovered in 1961 and it took 60 years until the first mRNA became FDA-approved product in the form of COVID-19 mRNA vaccine. During those…”
Get full text
Journal Article -
2
Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema
Published in Nature communications (08-06-2021)“…Lack or dysfunction of the lymphatics leads to secondary lymphedema formation that seriously reduces the function of the affected organs and results in…”
Get full text
Journal Article -
3
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
Published in Nature (London) (09-03-2017)“…A single, low-dose intradermal immunization with lipid-nanoparticle-encapsulated nucleoside-modified mRNA encoding the pre-membrane and envelope glycoproteins…”
Get full text
Journal Article -
4
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
Published in Molecular therapy. Nucleic acids (15-04-2019)“…Despite the enormous effort in the development of effective vaccines against HIV-1, no vaccine candidate has elicited broadly neutralizing antibodies in…”
Get full text
Journal Article -
5
Inhibition of Toll-like Receptor and Cytokine Signaling-A Unifying Theme in Ischemic Tolerance
Published in Journal of Cerebral Blood Flow & Metabolism (01-11-2004)“…Cerebral ischemia triggers acute inflammation, which exacerbates primary brain damage. Activation of the innate immune system is an important component of this…”
Get full text
Journal Article Book Review -
6
In vitro-Transcribed mRNA Therapeutics: Out of the Shadows and Into the Spotlight
Published in Molecular therapy (10-04-2019)“…Warren and Lin2 review this field and give an exquisite account of the development of IVT mRNA encoding key transcription factors for production of human stem…”
Get full text
Journal Article -
7
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
Published in Journal for immunotherapy of cancer (01-09-2022)“…BackgroundPediatric brain tumors are the leading cause of cancer death in children with an urgent need for innovative therapies. Glypican 2 (GPC2) is a cell…”
Get full text
Journal Article -
8
mRNA-based therapeutics — developing a new class of drugs
Published in Nature reviews. Drug discovery (01-10-2014)“…Key Points Messenger RNA (mRNA) is a pivotal molecule of life, involved in almost all aspects of cell biology. As the subject of basic and applied research for…”
Get full text
Journal Article -
9
Modified uridines are the key to a successful message
Published in Nature reviews. Immunology (01-10-2021)“…Katalin Karikó describes the discovery that replacing uridine with pseudouridine renders RNA non-immunogenic. This paved the way for developing mRNA for…”
Get full text
Journal Article -
10
Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models
Published in Science translational medicine (08-09-2021)“…Local immunotherapy ideally stimulates immune responses against tumors while avoiding toxicities associated with systemic administration. Current strategies…”
Get more information
Journal Article -
11
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Published in Nucleic acids research (01-11-2011)“…In vitro-transcribed mRNA has great therapeutic potential to transiently express the encoded protein without the adverse effects of viral and DNA-based…”
Get full text
Journal Article -
12
mRNA: Fulfilling the Promise of Gene Therapy
Published in Molecular therapy (01-09-2015)Get full text
Journal Article -
13
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
Published in Science (American Association for the Advancement of Science) (08-01-2021)“…The ability to control autoreactive T cells without inducing systemic immune suppression is the major goal for treatment of autoimmune diseases. The key…”
Get full text
Journal Article -
14
Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine
Published in Molecular therapy (04-05-2022)“…Lipid nanoparticle (LNP)-formulated nucleoside-modified mRNA vaccines have proven to be very successful in the fight against the coronavirus disease 2019…”
Get full text
Journal Article -
15
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
Published in Molecular therapy. Nucleic acids (15-04-2019)“…The increasing importance of in vitro-transcribed (IVT) mRNA for synthesizing the encoded therapeutic protein in vivo demands the manufacturing of pure mRNA…”
Get full text
Journal Article -
16
The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy
Published in Molecular therapy (10-04-2019)“…Adoptive T cell therapy is a form of cellular therapy that utilizes human immune cells, often empowered by the expression of recombinant proteins, to attack…”
Get full text
Journal Article -
17
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
Published in Nature medicine (01-07-2017)“…Bispecific antibodies that connect T cells with tumor cells can be delivered in the form of in vitro –transcribed pharmacologically optimized mRNA; when…”
Get full text
Journal Article -
18
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Published in Nature communications (22-08-2018)“…Currently available influenza virus vaccines have inadequate effectiveness and are reformulated annually due to viral antigenic drift. Thus, development of a…”
Get full text
Journal Article -
19
Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding Erythropoietin
Published in Molecular therapy (01-05-2012)“…Advances in the optimization of in vitro-transcribed mRNA are bringing mRNA-mediated therapy closer to reality. In cultured cells, we recently achieved high…”
Get full text
Journal Article -
20
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
Published in Nature communications (02-03-2017)“…Monoclonal antibodies are one of the fastest growing classes of pharmaceutical products, however, their potential is limited by the high cost of development…”
Get full text
Journal Article